Jefferies Group LLC Athira Pharma, Inc. Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	BUY	$2.74 - $13.43 $433,635 - $2.13 Million	158,261 Added 368.05%	201,261 $613,000
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $433,635 - $2.13 Million	158,261 Added 368.05%	201,261 $614,000
Q4 2021 Sep 21, 2023	BUY	$9.17 - $16.39 $394,310 - $704,770	43,000 New	43,000 $560,000
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $394,310 - $704,770	43,000 New	43,000 $560,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.